Go Pro
NASDAQ:KIDS

OrthoPediatrics Q3 2024 Earnings Report

OrthoPediatrics logo
$22.16 +0.47 (+2.17%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$22.14 -0.02 (-0.09%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics EPS Results

Actual EPS
-$0.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

OrthoPediatrics Revenue Results

Actual Revenue
$54.57 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OrthoPediatrics Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

OrthoPediatrics' Q3 2026 earnings is estimated for Tuesday, October 27, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

OrthoPediatrics Earnings Headlines

OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher
See More OrthoPediatrics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OrthoPediatrics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OrthoPediatrics and other key companies, straight to your email.

About OrthoPediatrics

OrthoPediatrics (NASDAQ:KIDS) is a medical device company focused exclusively on developing and commercializing orthopedic products for children. Headquartered in Warsaw, Indiana, the company designs implants and instruments intended to address the distinct anatomical and clinical needs of pediatric patients, including those whose bones are still growing.

Its product portfolio includes systems for pediatric trauma and deformity correction, scoliosis treatment, limb reconstruction, and pediatric sports medicine. Key product lines include the PediLoc and PediPlates systems, which are designed for fracture fixation and corrective procedures, as well as specialized implants and instrumentation used by orthopedic surgeons in treating congenital conditions, growth-related deformities, and other musculoskeletal disorders.

Founded in 2006, OrthoPediatrics markets its products through a direct sales organization and distribution partners to children's hospitals, medical centers, and orthopedic practices. The company serves customers in the United States and international markets, supporting pediatric orthopedic surgeons and healthcare providers in multiple regions. David Bailey has served as the company's chief executive officer.

View OrthoPediatrics Profile